The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata

References

• Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243–260.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
   PubMed Web of Science ®Google Scholar
• Lichtenstern C, Nguyen TH, Schemmer P, Hoppe-Tichy T, Weigand MA. Efficacy of caspofungin in invasive candidiasis and candidemia – de-escalation strategy. Mycoses 2008; 51: 35–46.
   Google Scholar
• Ruhnke M, Hartwig K, Kofia G. New options for treatment of candidaemia in critically ill patients. Clin Microbiol Infect 2008; 14: 46–54.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Boyken L, . Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol 2004; 42: 3142–3146.
   PubMed Web of Science ®Google Scholar
• Sanguinetti M, Posteraro B, Fiori B, . Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother; 2005; 49: 668–679.
   PubMed Web of Science ®Google Scholar
• Posteraro B, Sanguinetti M, Fiori B, . Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes. J Antimicrob Chemother 2006; 58: 458–461.
   Google Scholar
• Ito JI, Hooshmand-Rad R. Treatment of Candida infections with amphotericin B lipid complex. Clin Infect Dis 2005; 40: 384–391.
   Google Scholar
• Ellepola ANB, Samaranayake LP. Oral candidal infections and anti-mycotics. Crit Rev Oral Biol Med 2000; 11: 172–198.
   PubMedGoogle Scholar
• Turnidge JD, Gudmundsson S, Vogelman B, Craig WA. The postantibiotic effect of antifungal agents against common pathogenic yeasts. J Antimicrob Chemother 1994; 34: 83–92.
   PubMed Web of Science ®Google Scholar
• Craig WA, Gudmundsson S. The postantibiotic effect. Lorian V. Antibiotics in Laboratory Medicine. Baltimore: Williams & Wilkins, 1996: 403–431.
   Google Scholar
• Egusa H, Ellepola ANB, Nikawa H, Hamada T, Samaranayake LP. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell-surface-hydrophobicity of oral Candida albicans isolates. J Oral Pathol Med 2000; 29: 206–213.
   Google Scholar
• Ellepola ANB, Panagoda GJ, Samaranayake LP. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. Oral Microbiol Immunol 1999; 14: 358–363.
   Google Scholar
• Lyon, JP, Aparecida de Resende M. Evaluation of adhesion to buccal epithelial cells in Candida species obtained from denture wearers after exposure to fluconazole. Mycoses 2006; 50: 21–24.
   Google Scholar
• Clancy CJ, Huang H, Cheng S, Derendorf H, Nguyen MH. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments. Antimicrob Agents Chemother 2006; 50: 2569–2572.
   PubMed Web of Science ®Google Scholar
• Silverman Jr S, Migliorati CA, Epstein JB, Samaranayake LP. Laboratory diagnosis of oral candidosis, 213–237. Samaranayake L. P., MacFarlane T. W. Oral Candidiasis. London, England: Wright-Butterworth, 1990.
   Google Scholar
• McGinnis MR, Rinaldi MG. Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing and assays of activity in biological fluids, 176–211. Lorian V. Antibiotics in Laboratory Medicine. Baltimore: Williams & Wilkins, 1996.
   Google Scholar
• Löwdin E, Odenholt-Tornqvist I, Bengtsson S, Cars O. A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations. Antimicrob Agents Chemother 1993; 37: 2200–2205.
   PubMed Web of Science ®Google Scholar
• Kimura LH, Pearsall NN. Adherence of C. albicans to human buccal epithelial cells. Infect Immun 1978; 21: 64–68.
   PubMed Web of Science ®Google Scholar
• Sweet SP, MacFarlane TW, Samaranayake LP. Determination of the cell-surface-hydrophobicity of oral bacteria using a modified hydrocarbon adherence method. FEMS Microbiol Lett 1987; 48: 159–163.
   Web of Science ®Google Scholar
• Samaranayake LP, MacFarlane TW. An in vitro study of the adherence of C. albicans to acrylic surfaces. Arch Oral Biol 1980; 25: 603–609.
   PubMed Web of Science ®Google Scholar
• Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm forming ability of Candida albicans is unlikely to contribute to high oral yeast carriage in human immunodeficiency virus-infection. J Clin Microbiol 2003; 41: 2961–2967.
   PubMed Web of Science ®Google Scholar
• Garcia MT, Llorente MT, Minguez F, Prieto J. Influence of temperature and concentration on the postantifungal effect and the effects of sub-MIC concentrations of four antifungal agents on previously treated Candida species. Chemotherapy 2000; 46: 245–52.
   Google Scholar
• Dorocka-Bobkowska B, Konopka K, Düzgünes N. Influence of antifungal polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro. Arch Oral Biol 2003; 48: 805–814.
   PubMed Web of Science ®Google Scholar
• Samaranayake YH, Wu PC, Samaranayake LP, So M. Relationship between the cell-surface-hydrophobicity and adherence of Candida krusei and Candida albicans to epithelial and denture acrylic surfaces. APMIS 1995; 103: 707–13.
   Web of Science ®Google Scholar
• Panagoda GJ, Ellepola ANB, Samaranayake LP. Adhesion to denture acrylic surfaces and relative cell-surface-hydrophobicity of C. parapsilosis and C. albicans. APMIS 1998; 106: 736–742.
   Google Scholar
• Luo G, Samaranayake LP. Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell-surface-hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans. APMIS 2002; 110: 601–610.
   PubMed Web of Science ®Google Scholar
• Hazen KC, Hazen BW. Hydrophobic surface protein masking by the opportunistic fungal pathogen C. albicans. Infect Immun 1992; 60: 1499–1508.
   PubMed Web of Science ®Google Scholar
• Shibl AM, Ramadan MA, Tawfik AF. Post-antibiotic effect of roxithromycin on streptolysin production, hydrophobicity and bactericidal activity of PMNL by Streptococcus pyogenes. Diagn Microbiol Infect Dis 1994; 20: 7–11.
   PubMed Web of Science ®Google Scholar
• Cross LJ, Bagg J, Aitchison TC. Efficacy of the cyclodextrin liquid preparation of itraconazole in treatment of denture stomatitis: comparison with itraconazole capsules. Antimicrob Agents Chemother 2000; 44: 425–427.
   Google Scholar